cyclic system. Effects on mu and delta opioid receptor binding af®nities, and on potencies and ef®cacies as measured by the The existence of at least three types of opioid receptors, namely mu, delta and kappa, is widely accepted. Study of the interactions of structurally diverse ligands with the opioid receptors has led to the identi®cation of pharmacophore models, which detail the spatial arrangement of structural features common to all ligands of a particular receptor.
These models can be further re®ned through the design and study of conformationally restricted ligands, many of which display selectivity in binding to one or other opioid receptor.
The endogenous opioid pentapeptides lend themselves well to this approach. The cyclic disul®de-containing analog
displays such high af®nity and selectivity for the delta opioid receptor that it is considered the standard delta ligand (1). We have previously described a series of conformationally restricted disul®de-or dithioether-containing tetrapeptides that can be thought of as des-Gly 3 analogs of DPDPE (2), with the general structure depicted in Fig. 1 Also the results suggest that the structural requirements for binding to the mu or delta opioid receptor are not necessarily the same as the requirements for activation of the receptor.
Experimental Procedures
Peptide synthesis
All peptides (Table 1) were prepared using standard solidphase methods similar to those described previously for the synthesis of JOM-6 (2), using chloromethylated polystyrene (Merri®eld) resin cross-linked with 1% divinylbenzene.
Tri¯uoroacetic acid (TFA) was used for deprotection and dicyclohexylcarbodiimide (DCC) and 1-hydroxybenzotriazole (HOBt) were employed to facilitate coupling. Alphaamino functions were t-butyloxycarbonyl (Boc) protected, and p-methylbenzene protection was employed for the labile side chain sulfhydyl groups of Cys and Pen. Simultaneous deprotection and cleavage from the resin were accomplished by treatment with anhydrous hydrogen¯uoride in the presence of 5% p-cresol and 5% p-thiocresol for 45 min (6) at 08C. Prior to cyclization, linear peptides were puri®ed by reverse-phase high-performance chromatography (RP- Table 1 . All procedures were performed at 48C.
Radioligand-binding assays
Binding assays were based on the displacement by the test compounds of radiolabeled ([ 3 H]) ligands from opioid 
Results and Discussion
The following modi®ed and naturally occurring amino 
Radioligand-binding assays
Af®nities of the cyclic peptides for mu, delta and kappa opioid receptors are shown in Table 2 the peptide ring system is important in allowing for correct orientation within the binding pocket of the kappa opioid receptor.
GTPcS binding assays
The potencies and relative ef®cacies of the cyclic peptides for the mu opioid receptors are shown in Table 3 . 1000-fold functional selectivity for the mu over the 
